Papers
7
Total Citations
55
H-Index
6
About
Dr. Kuo-How Huang is a leading urologic oncologist whose research centers on optimizing surgical and diagnostic strategies for prostate cancer, with a particular focus on robotic-assisted radical prostatectomy (RARP). His work has been instrumental in evaluating whether robotic surgery delivers on its promise of improved oncological and quality-of-life outcomes compared to standard open procedures, as demonstrated in his highly cited 2013 review. Dr. Huang has made significant contributions to preoperative risk stratification, showing that biomarkers like %p2PSA and the Prostate Health Index (PHI) can predict aggressive pathology, and that paradoxically low PSA levels in high-grade disease may signal greater progression risk. His comparative effectiveness research, using propensity score matching, has provided critical evidence on the trade-offs between radical prostatectomy and radiotherapy with androgen deprivation therapy for locally advanced prostate cancer. With over 55 citations across his most impactful papers, Dr. Huang’s work consistently bridges surgical innovation with evidence-based patient selection. His recent analysis of adverse events in da Vinci robotic surgery from the MAUDE database underscores his commitment to patient safety and continuous improvement in minimally invasive techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7